Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

A longitudinal assessment of haloperidol doses and serum concentrations in Asian and Caucasian schizophrenic patients.

Lin KM, Poland RE, Nuccio I, Matsuda K, Hathuc N, Su TP, Fu P.

Am J Psychiatry. 1989 Oct;146(10):1307-11.

PMID:
2782476
2.

Effects of repeated drug holidays on serum haloperidol concentrations, psychiatric symptoms, and movement disorders in schizophrenic patients.

Newton JE, Cannon DJ, Couch L, Fody EP, McMillan DE, Metzer WS, Paige SR, Reid GM, Summers BN.

J Clin Psychiatry. 1989 Apr;50(4):132-5.

PMID:
2925601
3.

RBC and plasma levels of haloperidol and clinical response in schizophrenia.

Smith RC, Vroulis G, Shvartsburd A, Allen R, Lewis N, Schoolar JC, Chojnacki M, Johnson R.

Am J Psychiatry. 1982 Aug;139(8):1054-6.

PMID:
7091432
4.
5.

Haloperidol concentrations elevated in Chinese patients.

Potkin SG, Shen Y, Pardes H, Phelps BH, Zhou D, Shu L, Korpi E, Wyatt RJ.

Psychiatry Res. 1984 Jun;12(2):167-72.

PMID:
6591221
6.

Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers.

Artaloytia JF, Arango C, Lahti A, Sanz J, Pascual A, Cubero P, Prieto D, Palomo T.

Am J Psychiatry. 2006 Mar;163(3):488-93.

PMID:
16513871
7.

The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.

Marder SR, Davis JM, Chouinard G.

J Clin Psychiatry. 1997 Dec;58(12):538-46. Erratum in: J Clin Psychiatry 1998 Apr;59(4):200.

PMID:
9448657
8.

Haloperidol and reduced haloperidol plasma levels in Chinese vs. non-Chinese psychiatric patients.

Jann MW, Chang WH, Davis CM, Chen TY, Deng HC, Lung FW, Ereshefsky L, Saklad SR, Richards AL.

Psychiatry Res. 1989 Oct;30(1):45-52.

PMID:
2594870
9.

The assessment and clinical implications of haloperidol acute-dose, steady-state, and withdrawal pharmacokinetics.

Khot V, DeVane CL, Korpi ER, Venable D, Bigelow LB, Wyatt RJ, Kirch DG.

J Clin Psychopharmacol. 1993 Apr;13(2):120-7.

PMID:
8463444
10.

Haloperidol dosing requirements: the contribution of smoking and nonlinear pharmacokinetics.

Perry PJ, Miller DD, Arndt SV, Smith DA, Holman TL.

J Clin Psychopharmacol. 1993 Feb;13(1):46-51.

PMID:
8486817
11.

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

Kane JM, Carson WH, Saha AR, McQuade RD, Ingenito GG, Zimbroff DL, Ali MW.

J Clin Psychiatry. 2002 Sep;63(9):763-71.

PMID:
12363115
12.
13.

The relationship between plasma haloperidol concentrations and clinical results.

Palao DJ, Ara├║xo A, Haro JM, Brunet M, Bernardo M.

Arch Gen Psychiatry. 1996 Dec;53(12):1167-9. No abstract available.

PMID:
8956684
14.

Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patients.

Hollister LE, Kim DY.

Am J Psychiatry. 1982 Nov;139(11):1466-8.

PMID:
7137396
15.

The interpretation of plasma haloperidol concentrations.

Kirch DG, Bigelow LB, Wyatt RJ.

Arch Gen Psychiatry. 1985 Aug;42(8):838-40. No abstract available.

PMID:
4015329
16.

Reduced haloperidol does not interfere with the antipsychotic activity of haloperidol in the treatment of acute schizophrenia.

Ulrich S, Neuhof S, Braun V, Meyer FP.

Int Clin Psychopharmacol. 1999 Jul;14(4):219-28.

PMID:
10468314
17.

Haloperidol: therapeutic window in schizophrenia.

Palao DJ, Arauxo A, Brunet M, Bernardo M, Haro JM, Ferrer J, Gonzalez-Monclus E.

J Clin Psychopharmacol. 1994 Oct;14(5):303-10.

PMID:
7806684
18.

Relationship of serum haloperidol levels to clinical response in schizophrenic patients.

Magliozzi JR, Hollister LE, Arnold KV, Earle GM.

Am J Psychiatry. 1981 Mar;138(3):365-7.

PMID:
7468835
19.

[Standard and high doses of haloperidol. Clinical, pharmacokinetic and pharmacodynamic aspects].

Schilkrut R, Haverbeck C, Duran E, Delgado S, Kohen P, Birkner R, Katz I.

Acta Psiquiatr Psicol Am Lat. 1981 Sep-Nov;27(4-5):315-24. Spanish.

PMID:
7348089
20.

Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia.

Santos JL, Cabranes JA, Vazquez C, Fuentenebro F, Almoguera I, Ramos JA.

Biol Psychiatry. 1989 Aug;26(4):381-8.

PMID:
2669981

Supplemental Content

Support Center